Sleep. 1997 Jun;20(6):406-22.
These clinical guidelines, which have been reviewed and approved by the Board of Directors of the American Sleep Disorders Association, provide recommendations for the practice of sleep medicine in North America regarding the indications for polysomnography in the diagnosis of sleep disorders. Diagnostic categories that are considered include the following: sleep-related breathing disorders; neuromuscular disorders and sleep-related symptoms; chronic lung disease; narcolepsy; parasomnias; sleep-related epilepsy; restless legs syndrome; periodic limb movement disorder; depression with insomnia; and circadian rhythm sleep disorders. Whenever possible, conclusions are based on evidence from review of the literature. Where scientific data are absent, insufficient, or inconclusive, recommendations are based on consensus of opinion. The Standards of Practice Committee of the American Sleep Disorders Association appointed a task force to review the topic, the indications for polysomnography and related procedures. Based on the review and on consultation with specialists, the subsequent recommendations were developed by the Standards of Practice Committee and approved by the Board of Directors of the American Sleep Disorders Association. Polysomnography is routinely indicated for the diagnosis of sleep-related breathing disorders; for continuous positive airway pressure (CPAP) titration in patients with sleep-related breathing disorders; for documenting the presence of obstructive sleep apnea in patients prior to laser-assisted uvulopalatopharyngoplasty; for the assessment of treatment results in some cases; with a multiple sleep latency test in the evaluation of suspected narcolepsy; in evaluating sleep-related behaviors that are violent or otherwise potentially injurious to the patient or others; and in certain atypical or unusual parasomnias. Polysomnography may be indicated in patients with neuromuscular disorders and sleep-related symptoms; to assist in with the diagnosis of paroxysmal arousals or other sleep disruptions thought to be seizure-related; in a presumed parasomnia or sleep-related epilepsy that does not respond to conventional therapy; or when there is a strong clinical suspicion of periodic limb movement disorder. Polysomnography is not routinely indicated to diagnose chronic lung disease; in cases of typical, uncomplicated, and noninjurious parasomnias when the diagnosis is clearly delineated; for patients with epilepsy who have no specific complaints consistent with a sleep disorder; to diagnose or treat restless legs syndrome; for the diagnosis of circadian rhythm sleep disorders; or to establish a diagnosis of depression.
这些临床指南已经过美国睡眠障碍协会董事会的审核与批准,针对北美地区睡眠医学实践中多导睡眠图在睡眠障碍诊断方面的适应证给出了建议。所考虑的诊断类别包括以下几种:睡眠相关呼吸障碍;神经肌肉疾病及睡眠相关症状;慢性肺病;发作性睡病;异态睡眠;睡眠相关癫痫;不宁腿综合征;周期性肢体运动障碍;伴有失眠的抑郁症;以及昼夜节律睡眠障碍。只要有可能,结论均基于对文献综述的证据。在科学数据缺失、不足或不确定的情况下,建议基于意见共识。美国睡眠障碍协会实践标准委员会指定了一个特别工作组来审查该主题、多导睡眠图及相关程序的适应证。基于此次审查并经与专家磋商,随后的建议由实践标准委员会制定,并经美国睡眠障碍协会董事会批准。多导睡眠图常规用于诊断睡眠相关呼吸障碍;用于睡眠相关呼吸障碍患者的持续气道正压通气(CPAP)滴定;用于在激光辅助悬雍垂腭咽成形术前记录患者是否存在阻塞性睡眠呼吸暂停;用于在某些情况下评估治疗效果;与多次睡眠潜伏期试验一起用于评估疑似发作性睡病;用于评估对患者自身或他人有暴力行为或其他潜在伤害的睡眠相关行为;以及用于某些非典型或不寻常的异态睡眠。多导睡眠图可能适用于患有神经肌肉疾病及睡眠相关症状的患者;有助于诊断被认为与癫痫相关的阵发性觉醒或其他睡眠中断;对于对传统治疗无反应的疑似异态睡眠或睡眠相关癫痫;或者当临床高度怀疑周期性肢体运动障碍时。多导睡眠图通常不用于诊断慢性肺病;对于诊断明确的典型、无并发症且无伤害性的异态睡眠病例;对于没有与睡眠障碍相符的特定主诉的癫痫患者;用于诊断或治疗不宁腿综合征;用于诊断昼夜节律睡眠障碍;或者用于确立抑郁症的诊断。